540181 SALEM

Salem Erode Investments Share Price

 

Stock Result Declared

 

Start SIP in SALEM

Start SIP

Performance

  • Low
  • ₹31
  • High
  • ₹32
  • 52 Week Low
  • ₹29
  • 52 Week High
  • ₹66
  • Open Price₹32
  • Previous Close₹30
  • Volume8
  • 50 DMA₹35.38
  • 100 DMA₹37.66
  • 200 DMA₹40.38

Investment Returns

  • Over 1 Month -20.91%
  • Over 3 Month -19.05%
  • Over 6 Month -23.51%
  • Over 1 Year -33.28%

Smart Investing Starts Here Start SIP with Salem Erode Investments for Steady Growth!

Invest Now

Salem Erode Investments Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • -7.7
  • PEG Ratio
  • -1
  • Market Cap Cr
  • 36
  • P/B Ratio
  • 2.1
  • Average True Range
  • 1.59
  • EPS
  • -
  • Dividend Yield
  • 0
  • MACD Signal
  • -1.6
  • RSI
  • 32.25
  • MFI
  • 31.87

Salem Erode Investments Financials

Salem Erode Investments Technicals

EMA & SMA

Current Price
₹31.36
+ 1 (3.29%)
pointer
  • Bearish Moving Average 14
  • Bullish Moving Average 2
  • 20 Day
  • ₹32.79
  • 50 Day
  • ₹35.38
  • 100 Day
  • ₹37.66
  • 200 Day
  • ₹40.38

Resistance and Support

30.41 Pivot Speed
  • R3 30.61
  • R2 30.56
  • R1 30.46
  • S1 30.31
  • S2 30.26
  • S3 30.16

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Salem Erode Investments has an operating revenue of Rs. 3.67 Cr. on a trailing 12-month basis. An annual revenue de-growth of -6% needs improvement, Pre-tax margin of -129% needs improvement, ROE of -24% is poor and needs improvement. From an O'Neil Methodology perspective, the stock has an EPS Rank of 17 which is a POOR score indicating inconsistency in earnings, a RS Rating of 12 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at D- which indicates heavy supply, Group Rank of 76 indicates it belongs to a poor industry group of Finance-Investment Mgmt and a Master Score of E is the worst. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment. Please note that this is a thinly traded stock.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Salem Erode Investments Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-02-12 Quarterly Results
2026-01-30 Others
2025-11-13 Quarterly Results
2025-11-08 Others Inter-alia, to consider 1. Fund raising by way of issue of Secured Redeemable Non-Convertible Debentures on Private Placement basis. alia, 1. To consider and approve offer & issue of 50,699 Unlisted, Secured, Redeemable, Non-Convertible Debentures of face value of Rs. 1000/- each, at par, on private placement basis.
2025-09-23 Others Inter alia, to consider and approve 1. Fund raising by way of issue of Secured Redeemable Non-Convertible Debentures on Private Placement basis. alia, 1. To consider and approve offer & issue of 50,699 Unlisted, Secured, Redeemable, Non-Convertible Debentures of face value of Rs. 1000/- each, at par, on private placement basis.

Salem Erode Investments F&O

Salem Erode Investments Shareholding Pattern

75%
0.73%
14.47%
9.8%

About Salem Erode Investments

  • NSE Symbol
  • SALEM
  • BSE Symbol
  • 540181
  • Managing Director
  • Mr. K G Anilkkumar
  • ISIN
  • INE894E01028

Similar Stocks to Salem Erode Investments

Salem Erode Investments FAQs

Salem Erode Investments share price is ₹31 As on 13 February, 2026 | 15:48

The Market Cap of Salem Erode Investments is ₹36 Cr As on 13 February, 2026 | 15:48

The P/E ratio of Salem Erode Investments is -7.7 As on 13 February, 2026 | 15:48

The PB ratio of Salem Erode Investments is 2.1 As on 13 February, 2026 | 15:48

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23